Saturday, July 22, 2017 12:54:10 PM
i run acros a post like this that pretty much sums up what we are waiting on and why i love the part in red
There are a few holders/buyers who believe they will get the drug through trials and this is a $1+ stock. When the stock drops to trips they buy shares for the run they believe will come.
Lots of the old holders did this prior to the stock going to a dime during the Bio harp run. Many of them made a huge amount of cash.
I won't buy anymore shares, but have been holding. That is why I say always say I am holding for boom or bust. This stock has done well for me in the past few runs. I don't know if it will again, but if you do research you can do the math to understand that if the drug gets through trials(long shot), this could easily be a $2 stock. For some the chance of retirement is worth the gamble to buy in the trips.
So 10M shares at 001 is 10K for the potential return in about a year after trials start is maybe 15 to 25 million, some of the holder/buyers here will say more than than that...,, so the risk vs reward here is "worth it" for them!
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM